Immunohistochemistry Market to Hit $3.77 Billion by 2028 at 9.3% CAGR, Driven by Automation and Digital Pathology

The Business Research Company has recently revised its global market reports, now incorporating the most current data for 2024 along with projections extending up to 2033.

Immunohistochemistry (IHC) Global Market Report 2024 by The Business Research Company offers comprehensive market insights, empowering businesses with a competitive edge. It includes detailed estimates for numerous segments and sub-segments, providing valuable strategic guidance.

The Market Size Is Expected To Reach $3.77 billion In 2028 At A CAGR Of 9.3%.

The immunohistochemistry (ihc) market size has grown strongly in recent years. It will grow from $2.43 billion in 2023 to $2.65 billion in 2024 at a compound annual growth rate (CAGR) of 8.8%. The growth in the historic period can be attributed to clinical adoption, industry standardization, expansion in cancer research, automation in laboratories, clinical diagnostics advancements..

The immunohistochemistry (ihc) market size is expected to see strong growth in the next few years. It will grow to $3.77 billion in 2028 at a compound annual growth rate (CAGR) of 9.3%. The growth in the forecast period can be attributed to market entry of new players, demand in drug development, biomedical research integration, diagnostic applications, automation and digitalization. Major trends in the forecast period include multiplex ihc techniques, digital pathology integration, enhanced antibody specificity, automation and standardization, application in biomarker discovery..

Request A Sample Of This Report - https://www.thebusinessresearchcompany.com/sample.aspx?id=9267&type=smp

Immunohistochemistry (IHC) Market Major Segments
The immunohistochemistry (ihc) market covered in this report is segmented -
1) By Product: Antibodies, Equipment, Reagents, Kits
2) By Applications: Diagnostics, Drug Testing, Other Applications
3) By End-Users: Hospitals And Diagnostic Laboratories, Research Institutes, Other End-Users

Key Driver - Increase In Chronic Diseases Prevalence Boosts Immunohistochemistry (IHC) Market Growth

The increase in the prevalence of chronic diseases is expected to propel the immunohistochemistry (IHC) market going forward. Chronic diseases refer to clinical conditions that last for three months or more extended periods and usually can be controlled but not cured. Immunohistochemistry helps in diagnosing chronic diseases such as cancer, cardiovascular disorders, and others due to its various advantages, such as its specificity, sensitivity (used to detect specific antigens), rapid results, and others. For instance, in 2022, according to the Centers for Disease Control and Prevention, a US-based national public health agency, around 37.3 million people have diabetes which equals 11.3% of the United States population. Therefore, an increase in the prevalence of chronic diseases is driving the growth of the immunohistochemistry (IHC) market.

Customise This Report As Per Your Requirements - https://www.thebusinessresearchcompany.com/Customise?id=9267&type=smp

Prominent Trend - Technological Advancements Propel Innovation In Immunohistochemistry (IHC) Market

Technological advancement is the key trend in the immunohistochemistry (IHC) market. Major companies operating in the market are focused on developing technologically advanced products to strengthen their position in the market. For instance, in April 2021, Akoya Biosciences, Inc, a US-based company operating in end-to-end solutions for high-parameter tissue analysis, introduced its new multiplex detection kits based on Opal multiplex technology known as Akoya's Opal Multiplex Detection Kits. The opal multiplex technique is a methodology for detecting multiple biomarkers in one section of tissue that encompasses iterative single staining and heating-mediated removal of the primary stain. Akoya's Opal Multiplex Detection Kits provide phenotypic scoring using signal amplification, low sample and reagent consumption, can measure 3 to 8 IHC targets and nuclear stains, and other advanced features.

Immunohistochemistry (IHC) Market Players
Major companies operating in the immunohistochemistry (ihc) market report are Thermo Fisher Scientific Inc., F. Hoffmann-La Roche AG, The Merck Group, Danaher Corporation, PerkinElmer Inc., Bio-Rad Laboratories Inc., Cell Signaling Technology Inc., Bio SB Inc., Agilent Technologies Inc., Abcam plc, Becton Dickinson and Company, Takara Bio Inc., Biocare Medical LLC, Bio-Genex Laboratories, Diagnostic BioSystems Inc., BioVision Inc., PHC Holdings Corporation, Abbott Laboratories, Leica Biosystems, Vector Laboratories, Indivumed GmbH, Qritive, Ionpath Inc., Reveal Biosciences, Akrivis Technologies Private Limited, LifeSpan BioSciences Inc., Enzo Life Sciences Inc., Epitomics Inc., GenScript Biotech, Histologix Ltd., NeoGenomics Laboratories Inc. .

View The Full Report Here - https://www.thebusinessresearchcompany.com/report/immunohistochemistry-ihc-global-market-report

Largest And Fastest Growing Region In The Market
North America was the largest region in the immunohistochemistry (IHC) market in 2023. Asia-Pacific is expected to be the fastest-growing region in the immunohistochemistry (IHC) market report during the forecast period. The regions covered in the immunohistochemistry (ihc) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The Table Of Content For The Market Report Include:
1. Executive Summary
2. Immunohistochemistry (IHC) Market Report Structure
3. Immunohistochemistry (IHC) Market Trends And Strategies
4. Immunohistochemistry (IHC) Market - Macro Economic Scenario
5. Immunohistochemistry (IHC) Market Size And Growth
…..
27. Immunohistochemistry (IHC) Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.

This release was published on openPR.